TB control and access to second-line drugs: Better model needed

Bulletin of the World Health Organization

Volumn 80, Issue 6, 2002, Pages 495-496

  Espinal, Marcos A ^a   Zaleski, Richard ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

HEALTH CARE ACCESS; INFECTION CONTROL; MODEL; MULTIDRUG RESISTANCE; NOTE; RISK BENEFIT ANALYSIS; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0036276859     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Infectious disease policy: Towards the production of health
2. Resistencia a farmacos antituberculosis en fracasos a un esquema de tratamiento primario
3. Standard short-course chemotherapy for drug resistant tuberculosis
4. Rational 'DOTS-Plus' for the control of MDR-TB
5. Feasibility and cost-effectiveness of second-line drug treatment for chronic tuberculosis patients: A national cohort study in Peru